Home > Insider Trading > Filing (0001209191-14-074954)

Filing Details

Accession Number:: 0001209191-14-074954
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2014-12-12 16:05:19
Reporting Period:: 2014-12-10

Filing Date:: 2014-12-12
Accepted Time:: 2014-12-12 16:05:19
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1174940	Oragenics Inc	OGEN	Pharmaceutical Preparations (2834)	593410522

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1234877	Beverly Koski	3525 Turtle Creek Bouldevard, Unit 19-B Dallas TX 75219	No	No	Yes	No
1234878	L Christine Koski	3525 Turtle Creek Bouldevard, Unit 19-B Dallas TX 75219	Yes	No	Yes	No
1234879	Koski Family Lp	3525 Turtle Creek Boulevard, Unit 19-B Dallas TX 75219	No	No	Yes	No
1234880	C Robert Koski	7362 Hawkins Road Sarasota FL 34241	Yes	No	Yes	No
1234881	L Thomas Koski	4995 Ashley Parkway Sarasota FL 34241	No	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2014-12-10	100	$0.87	662,624	No	4	P	Direct
Common Stock	Acquisiton	2014-12-11	300	$0.81	662,924	No	4	P	Direct
Common Stock	Acquisiton	2014-12-11	200	$0.81	663,124	No	4	P	Direct
Common Stock	Acquisiton	2014-12-11	200	$0.82	663,324	No	4	P	Direct
Common Stock	Acquisiton	2014-12-11	200	$0.82	663,524	No	4	P	Direct
Common Stock	Acquisiton	2014-12-11	200	$0.82	663,724	No	4	P	Direct
Common Stock	Acquisiton	2014-12-11	100	$0.82	663,824	No	4	P	Direct
Common Stock	Acquisiton	2014-12-11	100	$0.83	663,924	No	4	P	Direct
Common Stock	Acquisiton	2014-12-11	300	$0.83	664,224	No	4	P	Direct
Common Stock	Acquisiton	2014-12-11	600	$0.84	664,824	No	4	P	Direct
Common Stock	Acquisiton	2014-12-11	500	$0.84	665,324	No	4	P	Direct
Common Stock	Acquisiton	2014-12-11	100	$0.84	665,424	No	4	P	Direct
Common Stock	Acquisiton	2014-12-11	100	$0.84	665,524	No	4	P	Direct
Common Stock	Acquisiton	2014-12-11	200	$0.84	665,724	No	4	P	Direct
Common Stock	Acquisiton	2014-12-11	100	$0.85	665,824	No	4	P	Direct
Common Stock	Acquisiton	2014-12-11	200	$0.85	666,024	No	4	P	Direct
Common Stock	Acquisiton	2014-12-11	100	$0.85	666,124	No	4	P	Direct
Common Stock	Acquisiton	2014-12-11	4,500	$0.85	670,624	No	4	P	Direct
Common Stock	Acquisiton	2014-12-11	4,900	$0.87	675,524	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	8,257,742	Direct
Common Stock	1,086,323	Direct
Common Stock	519,666	Direct
Common Stock	20,000	Indirect	By Koski Management, Inc.
Common Stock	530,851	Indirect	By Trusts

Footnotes

Shares owned directly by Koski Family Limited Partnership. Shares owned indirectly by Beverly Koski (through Koski Management, Inc. solely owned by Beverly Koski), Christine L. Koski, Robert C. Koski and Thomas L. Koski, each of whom is a general partner of the partnership or the controlling person of a corporate general partner of the partnership.
Each reporting person disclaims beneficial ownership of all indirectly owned securities in excess of such reporting person's pecuniary interest therein, and this report shall not be deemed an admission that the reporting person is the beneficial owner for purposes of Section 16 or any other purpose.
Shares owned directly by Christine L. Koski.
Shares owned directly by Robert C. Koski.
Shares owned directly by Thomas L. Koski.
Shares owned indirectly by Beverly Koski (through Koski Management, Inc).
Shares owned by trusts of which Mr. Robert C. Koski is sole trustee. Such trusts are as follows: the Robert Clayton Koski Trust for the benefit of Anthony James Hunter (100,000 shares); the Robert Clayton Koski Trust for the benefit of Hunter Buchanan Koski (100,000 shares); the Robert Clayton Koski Trust for the benefit of Clayton Ward Bennett (100,000 shares); the Robert Clayton Koski Trust for the benefit of Robert Edward Koski (100,000 shares); and the Robert Clayton Koski Trust for the benefit of Elyse Margaux Koski (97,666 shares). Mr. Koski disclaims beneficial ownership of the shares held by the trusts except to the extent of any pecuniary interest.